References
- Hansen RA, Gartlehner G, Lohr KN, Gaynes BN, Carey TS. Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder. Ann Intern Med 2005; 143: 415–26
- Geddes JR, Freemantle N, Mason J, Eccles MP, Boynton J. SSRIs versus other antidepressants for depressive disorder. Cochrane Database Syst Rev 2000;CD001851.
- Anderson IM. Meta-analytical studies on new antidepressants. Br Med Bull 2001; 57: 161–78
- Olfson M, Marcus SC, Druss B, Elinson L, Tanielian T, Pincus HA. National trends in the outpatient treatment of depression. J Am Med Assoc 2002; 287: 203–9
- Guaiana G, Andretta M, Corbari L, et al. Antidepressant drug consumption and public health indicators in Italy, 1955 to 2000. J Clin Psychiatry 2005; 66: 750–5
- Gibbons RD, Hur K, Bhaumik DK, Mann JJ. The relationship between antidepressant medication use and rate of suicide. Arch Gen Psychiatry 2005; 62: 165–72
- Barak Y, Aizenberg D. The association between antidepressant prescribing and suicide in Israel. Int Clin Psychopharmacol 2006; 21: 281–4
- Fincke BG, Snyder K, Cantillon C, et al. Three complementary definitions of polypharmacy: methods, application and comparison of findings in a large prescription database. Pharmacoepidemiol Drug Saf 2005; 14: 121–8
- Frye MA, Ketter TA, Leverich GS, et al. The increasing use of polypharmacotherapy for refractory mood disorders: 22 years of study. J Clin Psychiatry 2000; 61: 9–15
- Kotzan JA, Maclean R, Wade W, et al. Prevalence and patterns of concomitant use of selective serotonin reuptake inhibitors and other antidepressants in a high-cost polypharmacy cohort. Clin Ther 2002; 24: 237–48
- Rubinow DR. Treatment strategies after SSRI failure – Good news and bad news. New Engl J Med 2006; 354: 1305–7
- IMS Retail Drug Monitor, IMS Health Incorporated; 2004.
- SAS/STAT Users’ Guide, Version 8, vols 1,2. Cary, NC: SAS Institute; 1994.
- Barbui C, Broglio E, Laia AC, et al. Cross-sectional database analysis of antidepressant prescribing in Italy. J Clin Psychopharmacol 2003; 23: 31–4
- McCue RE, Waheed R, Urcuyo L. Polypharmacy in patients with schizophrenia. J Clin Psychiatry 2003; 64: 984–9
- Linne AB, Liedholm H. Audit of prescribing practices in nursing homes. Many preparations but few serious interactions. Lakartidningen 2003; 10: 2360–5
- Linden M, Lecrubier Y, Bellantuono C, Benkert O, Kisely S, Simon G. The prescribing of psychotropic drugs by primary care physicians: an international collaborative study. J Clin Psychopharmacol 1999; 19: 132–4
- de las Cuevas C, Sanz EJ, de la Fuente JA, Cueto M. Polypharmacy in psychiatric patients as an alternative to limited mental health Resources. Actas Esp Psiquiatr 2005; 33: 81–6
- Silkey B, Preskorn SH, Golbeck A, et al. Complexity of medication use in the Veterans Affairs healthcare system: Part II. Antidepressant use among younger and older outpatients. J Psychiatr Pract 2005; 11: 16–26
- Patten SB, Beck C. Major depression and mental health care utilization in Canada: 1994 to 2000. Can J Psychiatry 2004; 49: 303–9
- van Dijk KN, de Vries CS, ter Huurne K, van den Berg PB, Brouwers JR, de Jong-van den Berg LT. Concomitant prescribing of benzodiazepines during antidepressant therapy in the elderly. J Clin Epidemiol 2002; 55: 1049–3
- Stahl SM. Antidepressant treatment of psychotic major depression: potential role of the sigma receptor. CNS Spectr 2005; 10: 319–23
- Simon J, Pilling S, Burbeck R, Goldberg D. Treatment options in moderate and severe depression: decision analysis supporting a clinical guideline. Br J Psychiatry 2006; 189: 494–501